Parkinson's Disease Trial, Recruiting NCT05748028 Sponsor: Istituti Clinici Scientifici Maugeri SpA Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT05748028
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Parkinson's Disease or Multiple System Atrophy based on current international medical guidelines.
  • People who score at least 10 out of 30 on a standard memory and thinking test called the Mini-Mental State Examination.

Who may not be able to join:

  • People whose movement symptoms are caused by blood vessel problems or by medication, rather than by Parkinson's Disease or Multiple System Atrophy.
  • People who have diabetes.
  • People who have liver or kidney conditions that affect the body's ability to process certain substances (confirm with trial site).
  • People who have an underactive or overactive thyroid gland.
  • People who are taking medications that may be harmful to the nervous system.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Maria Nolano, MD, PhD, Isituti Clinici Scientifici Maugeri SpA SB - IRCCS of Telese Terme

Phone: +390824909257

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istituti Clinici Scientifici Maugeri SpA
Registry
ClinicalTrials.gov
Start date
15 June 2019
Est. completion
30 September 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Prevalence and Characterization of Pain; Prevalence and Characterization of Pain

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov